Results 91 to 100 of about 334,579 (212)
Child with aplastic anemia: Anesthetic management
Aplastic anemia is a rare heterogeneous disorder of hematopoietic stem cells causing pancytopenia and marrow hypoplasia with the depletion of all types of blood cells.
Manpreet Kaur +3 more
doaj +1 more source
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
Régis Peffault de Latour +49 more
semanticscholar +1 more source
The Pathophysiology of Acquired Aplastic Anemia: Current Concepts Revisited
Idiopathic acquired aplastic anemia is a rare, life-threatening bone marrow failure syndrome characterized by cytopenias and hypocellular bone marrow. The pathophysiology is unknown; the most favored model is of a dysregulated immune system leading to ...
M. Schoettler, D. Nathan
semanticscholar +1 more source
ABSTRACT This retrospective, single‐center study aimed to characterize clonal dynamics of GPI‐deficient cells in patients with paroxysmal nocturnal hemoglobinuria (PNH) or PNH/aplastic anemia (AA) syndrome using multiparameter flow cytometry including FLAER.
Sandra M. Frey +6 more
wiley +1 more source
Perspective and Experience of Patients with Aplastic Anemia on Medication Adherence
Hangting Li,1,* Xiaolian Wu,1,* Jiaoni Shen,2 Shuhui Lou2 1Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, People’s Republic of China ...
Li H, Wu X, Shen J, Lou S
doaj
Exome sequencing identifies MPL as a causative gene in familial aplastic anemia
The primary cause of aplastic anemia remains unknown in many patients. The aim of this study was to clarify the genetic cause of familial aplastic anemia.
Amanda J. Walne +7 more
doaj +1 more source
ABSTRACT Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hematologic disorder caused by a defect of glycosylphosphatidyl‐anchored proteins, leading to an uncontrolled complement‐mediated hemolysis. The advent of complement inhibitors in clinical practice radically changed patients' outcomes and survival.
Bruno Fattizzo +8 more
wiley +1 more source
BackgroundHaploidentical donor (HID) hematopoietic stem cell transplantation (HSCT) is an alternative treatment method for severe aplastic anemia (SAA) patients lacking suitable identical donors and those who are refractory to immunosuppressive therapy ...
Lanping Xu +12 more
semanticscholar +1 more source

